Radiopharmaceuticals in Nuclear Medicine Market Report

Japan Radiopharmaceuticals in Nuclear Medicine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 15, 2019
  • PAGES：198
  • REPORT CODE：GMM230046
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Radiopharmaceuticals in Nuclear Medicine market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Radiopharmaceuticals in Nuclear Medicine market. Detailed analysis of key players, along with key growth strategies adopted by Radiopharmaceuticals in Nuclear Medicine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Institute Of Radioelement (IRE)

    • IBA Group

    • Institute of Isotopes Co., Ltd.

    • Covidien, Plc

    • Bracco Imaging S.P.A.

    • Institute of Isotopes Co, Ltd

    • POLATOM

    • Siemens Healthcare (Subsidiary Of Siemens AG)


    By Type:

    • Diagnostic Radiopharmaceuticals

    • Therapy Radiopharmaceuticals

    • Enriched Stable Isotopes


    By End-User:

    • Diagnostic Application

    • Therapeutic Application

    • Research

    • Pharmaceutical

    • Other


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Radiopharmaceuticals in Nuclear Medicine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic Radiopharmaceuticals from 2014 to 2026

      • 1.3.2 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapy Radiopharmaceuticals from 2014 to 2026

      • 1.3.3 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Enriched Stable Isotopes from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic Application from 2014 to 2026

      • 1.4.2 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapeutic Application from 2014 to 2026

      • 1.4.3 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Research from 2014 to 2026

      • 1.4.4 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Pharmaceutical from 2014 to 2026

      • 1.4.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Radiopharmaceuticals in Nuclear Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Radiopharmaceuticals in Nuclear Medicine by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Radiopharmaceuticals

      • 3.4.2 Market Size and Growth Rate of Therapy Radiopharmaceuticals

      • 3.4.3 Market Size and Growth Rate of Enriched Stable Isotopes

    4 Segmentation of Radiopharmaceuticals in Nuclear Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Radiopharmaceuticals in Nuclear Medicine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Diagnostic Application

      • 4.4.2 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Therapeutic Application

      • 4.4.3 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Research

      • 4.4.4 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Pharmaceutical

      • 4.4.5 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Other


    5 Market Analysis by Regions

    • 5.1 Japan Radiopharmaceuticals in Nuclear Medicine Production Analysis by Regions

    • 5.2 Japan Radiopharmaceuticals in Nuclear Medicine Consumption Analysis by Regions


    6 Hokkaido Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 6.1 Hokkaido Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 6.2 Hokkaido Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    7 Tohoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 7.1 Tohoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 7.2 Tohoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    8 Kanto Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 8.1 Kanto Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 8.2 Kanto Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    9 Chubu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 9.1 Chubu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 9.2 Chubu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    10 Kinki Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 10.1 Kinki Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 10.2 Kinki Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    11 Chugoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 11.1 Chugoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 11.2 Chugoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    12 Shikoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 12.1 Shikoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 12.2 Shikoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    13 Kyushu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 13.1 Kyushu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 13.2 Kyushu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Institute Of Radioelement (IRE)

      • 14.1.1 Institute Of Radioelement (IRE) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 IBA Group

      • 14.2.1 IBA Group Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Institute of Isotopes Co., Ltd.

      • 14.3.1 Institute of Isotopes Co., Ltd. Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Covidien, Plc

      • 14.4.1 Covidien, Plc Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Bracco Imaging S.P.A.

      • 14.5.1 Bracco Imaging S.P.A. Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Institute of Isotopes Co, Ltd

      • 14.6.1 Institute of Isotopes Co, Ltd Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 POLATOM

      • 14.7.1 POLATOM Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Siemens Healthcare (Subsidiary Of Siemens AG)

      • 14.8.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 122 Figures and 134 Tables)

     

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic Radiopharmaceuticals from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapy Radiopharmaceuticals from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Enriched Stable Isotopes from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic Application from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapeutic Application from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Research from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Pharmaceutical from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Radiopharmaceuticals in Nuclear Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Radiopharmaceuticals in Nuclear Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Radiopharmaceuticals in Nuclear Medicine by Different Types from 2014 to 2026

    • Table Consumption Share of Radiopharmaceuticals in Nuclear Medicine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic Radiopharmaceuticals

    • Figure Market Size and Growth Rate of Therapy Radiopharmaceuticals

    • Figure Market Size and Growth Rate of Enriched Stable Isotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Radiopharmaceuticals in Nuclear Medicine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Radiopharmaceuticals in Nuclear Medicine by Different End-Users from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic Application from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapeutic Application from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Research from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Pharmaceutical from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Production by Regions

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions in 2014

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions in 2018

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions in 2026

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Consumption by Regions

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions in 2014

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions in 2018

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions in 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Institute Of Radioelement (IRE)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Institute Of Radioelement (IRE)

    • Figure Sales and Growth Rate Analysis of Institute Of Radioelement (IRE)

    • Figure Revenue and Market Share Analysis of Institute Of Radioelement (IRE)

    • Table Product and Service Introduction of Institute Of Radioelement (IRE)

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Institute of Isotopes Co., Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Institute of Isotopes Co., Ltd.

    • Figure Sales and Growth Rate Analysis of Institute of Isotopes Co., Ltd.

    • Figure Revenue and Market Share Analysis of Institute of Isotopes Co., Ltd.

    • Table Product and Service Introduction of Institute of Isotopes Co., Ltd.

    • Table Company Profile and Development Status of Covidien, Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Covidien, Plc

    • Figure Sales and Growth Rate Analysis of Covidien, Plc

    • Figure Revenue and Market Share Analysis of Covidien, Plc

    • Table Product and Service Introduction of Covidien, Plc

    • Table Company Profile and Development Status of Bracco Imaging S.P.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging S.P.A.

    • Figure Sales and Growth Rate Analysis of Bracco Imaging S.P.A.

    • Figure Revenue and Market Share Analysis of Bracco Imaging S.P.A.

    • Table Product and Service Introduction of Bracco Imaging S.P.A.

    • Table Company Profile and Development Status of Institute of Isotopes Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Institute of Isotopes Co, Ltd

    • Figure Sales and Growth Rate Analysis of Institute of Isotopes Co, Ltd

    • Figure Revenue and Market Share Analysis of Institute of Isotopes Co, Ltd

    • Table Product and Service Introduction of Institute of Isotopes Co, Ltd

    • Table Company Profile and Development Status of POLATOM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of POLATOM

    • Figure Sales and Growth Rate Analysis of POLATOM

    • Figure Revenue and Market Share Analysis of POLATOM

    • Table Product and Service Introduction of POLATOM

    • Table Company Profile and Development Status of Siemens Healthcare (Subsidiary Of Siemens AG)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare (Subsidiary Of Siemens AG)

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare (Subsidiary Of Siemens AG)

    • Figure Revenue and Market Share Analysis of Siemens Healthcare (Subsidiary Of Siemens AG)

    • Table Product and Service Introduction of Siemens Healthcare (Subsidiary Of Siemens AG)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US